iCardiac Technologies

iCardiac Technologies, Inc. is a technologically-differentiated cardiac core lab providing the industry’s most sophisticated ICH E14 compliant cardiac safety assessment methodologies for clinical studies, supported by scientific expertise, project management, worldwide site and equipment logistics, customer support & regulatory data submission. iCardiac’s next generation approach to cardiac safety services enables sponsors to reduce false positive QT results, characterize safety profile early, and accurately assess drugs that affect heart rate. Our automated analysis enables sponsors to gain efficiency and reproducibility. At the same time, we optimize the efficiency of clinical ECG studies with a state-of-the-art ECG equipment platform. The equipment platform is designed specifically for clinical trials to ensure high quality, cost- effective data centralization from global multi-site studies. Our team of scientists and board-certified cardiologists boast expertise in world-wide multi-center, clinical research studies ranging from 25-3,500 subjects. The team’s experience represents all major therapeutic areas and collectively they have 100 years of cardiology, electrophysiology, drug development, regulatory and academic experience.